African American Study of Kidney Disease and Hypertension ABPM Pilot Study

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Hypertensive Renal Disease
Interventions
BEHAVIORAL

USUAL - take your BP Meds as you usually do

The patient's antihypertensive regimen at the baseline visit is the comparison (or control) regimen. All once a day medications will be administered in the morning.

BEHAVIORAL

HS DOSING

Take your usual BP meds at bed time

DRUG

ADD On Dosing

Take your usual BP meds but add one more med at bed time.

Trial Locations (16)

10021

Lenox Hill Hospital, New York

21205

Johns Hopkins University, Baltimore

29425

Medical University of South Carolina, Charleston

30308

Emory University, Atlanta

32611

University of Florida, Gainesville

33101

University of Miami, Miami

35233

University of Alabama, Birmingham

37232

Vanderbilt University, Nashville

43210

Ohio State University, Columbus

44106

University Hospitals of Cleveland, Cleveland

48106

University of Michigan, Ann Arbor

60637

University of Chicago, Chicago

75390

Univesity of Texas Southwestern Medical Center at Dallas, Dallas

90033

University of Southern California, Los Angeles

90059

Charles Drew Medical College, Los Angeles

92161

University of California at San Diego, San Diego

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00582777 - African American Study of Kidney Disease and Hypertension ABPM Pilot Study | Biotech Hunter | Biotech Hunter